PI3K/Akt inhibitor partly decreases TNF-α-induced activation of fibroblast-like synoviocytes in osteoarthritis

被引:62
|
作者
Liu, Songyang [1 ]
Cao, Chenxi [1 ,2 ]
Zhang, Yujun [3 ,4 ]
Liu, Guangyu [1 ]
Ren, Weixia [3 ,4 ]
Ye, Yanqi [1 ]
Sun, Tiezheng [1 ]
机构
[1] Peking Univ, Peoples Hosp, Arthritis Clin & Res Ctr, Beijing 100044, Peoples R China
[2] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100044, Peoples R China
[3] Peking Univ, Peoples Hosp, Inst Clin Mol Biol, Beijing 100044, Peoples R China
[4] Peking Univ, Peoples Hosp, Cent Lab, Beijing 100044, Peoples R China
关键词
PI3K/Akt inhibitor; TNF-alpha; Cadherin-11; Osteoarthritis; Fibroblast-like synoviocytes; PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR; CADHERIN-11; ARTHRITIS; SYNOVITIS; PATHOLOGY; INFLAMMATION; PROGRESSION; EXPRESSION; MIGRATION; CELLS;
D O I
10.1186/s13018-019-1394-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: The Cadherin-11 and PI3K/Akt pathway are increasingly recognized as the potential therapeutic target of osteoarthritis (OA) synovitis. The study aimed to investigate the role of PI3K/Akt signaling pathway in the expression of Cadherin-11 and migration and invasive capacity of fibroblast-like synoviocytes (FLS) of OA patients under stimulation of TNF-alpha and to explore the effect of the PI3K/Akt inhibitor and Cadherin-11 antibody in the therapy of the collagenase-induced osteoarthritis (CIOA) mice. Methods: FLS were primarily cultured from synovium of osteoarthritic patients during total knee arthroplasty. Under the simulation of TNF-alpha, with or without PI3K/Akt inhibitor LY294002, Cadherin-11 expression was detected by real-time PCR and Western blot, as well as the migration and invasive capacity changes of OA FLS. Cadherin-11 antibody was injected intraarticularly or LY294002 was injected intraperitoneally in CIOA mice to evaluate the changes of synovitis score, cartilage damage, and Cadherin-11 expression. Results: TNF-alpha stimulation increased Cadherin-11 expression at mRNA and protein level in OA FLS and also increased the phosphorylation-dependent activation of Akt. PI3K inhibitor LY294002 attenuated TNF-alpha-induced overexpression of Cadherin-11 and decreased the invasive capacity of OA FLS. Intraperitoneal injection of PI3K inhibitor LY294002 could decrease the Cadherin-11 protein expression in synovium of CIOA mice, although it has no significant inhibitory effect on synovitis and cartilage damage. Intraarticular injection of Cadherin-11 antibody attenuated the synovitis and cartilage damage in the CIOA joints and decreased Cadherin-11 expression in the synovial lining. Conclusions: PI3K/Akt pathway was associated with TNF-alpha-induced activation of OA FLS, which may involve in the pathogenesis of osteoarthritis. Anti-Cadherin-11 therapy in CIOA mice could attenuate the pathological changes of OA joints.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway
    Chen, Kun
    Lin, Zhao-Wei
    He, Sheng-mao
    Wang, Cheng-qiang
    Yang, Jian-cheng
    Lu, Yao
    Xie, Xiao-bo
    Li, Qi
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [32] Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway
    Jing Tian
    Jin-wei Chen
    Jie-sheng Gao
    Len Li
    Xi Xie
    Rheumatology International, 2013, 33 : 1829 - 1835
  • [33] Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway
    Tian, Jing
    Chen, Jin-wei
    Gao, Jie-sheng
    Li, Len
    Xie, Xi
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (07) : 1829 - 1835
  • [34] Therapeutic effect of neohesperidin on TNF-α-stimulated human rheumatoid arthritis fibroblast-like synoviocytes
    WANG Xiao-He
    DAI Ce
    WANG Jun
    LIU Rui
    LI Lei
    YIN Zong-Sheng
    ChineseJournalofNaturalMedicines, 2021, 19 (10) : 741 - 749
  • [35] Therapeutic effect of neohesperidin on TNF-α-stimulated human rheumatoid arthritis fibroblast-like synoviocytes
    Wang Xiao-He
    Dai Ce
    Wang Jun
    Liu Rui
    Li Lei
    Yin Zong-Sheng
    CHINESE JOURNAL OF NATURAL MEDICINES, 2021, 19 (10) : 741 - 749
  • [36] INTERFERONS OVERRULE THE TNF-INDUCED PROLIFERATION OF RHEUMATOID FIBROBLAST-LIKE SYNOVIOCYTES
    Blits, Marjolein
    de Ridder, Sander
    Timmer, Trieneke C. G.
    Kasperkovitz, Pia V.
    Trujillo, Alejandro Martin
    van het Hof, Bert
    Kraan, Tineke C. T. M. van der Pouw
    Vosslamber, Saskia
    de Jong, Tamarah
    Wesseling, John
    Gringhuis, Sonja I.
    Verweij, Cornelis L.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A27 - A27
  • [37] 10-Hydroxy-2-decenoic acid inhibiting the proliferation of fibroblast-like synoviocytes by PI3K-AKT pathway
    Wang, Jianguang
    Zhang, Wei
    Zou, Hai
    Lin, Yaoyao
    Lin, Ke
    Zhou, Zhonghao
    Qiang, Jiaping
    Lin, Jialiang
    Chuka, Chifundo Martha
    Ge, Renshan
    Zhao, Shujiang
    Yang, Xinyu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 28 (01) : 97 - 104
  • [38] Upregulated expression of CCR3 in osteoarthritis and CCR3 mediated activation of fibroblast-like synoviocytes
    Chang, Xin
    Shen, Jirong
    Yang, Haiwei
    Xu, Yanan
    Gao, Wei
    Wang, Junling
    Zhang, Huiyun
    He, Shaoheng
    CYTOKINE, 2016, 77 : 211 - 219
  • [39] 6-Shogaol inhibits the proliferation, apoptosis, and migration of rheumatoid arthritis fibroblast-like synoviocytes via the PI3K/AKT/NF-κB pathway
    Li, Nan
    Li, Xiaojuan
    Deng, Lijuan
    Yang, Haixin
    Gong, Zhaohui
    Wang, Qiang
    Pan, Dongmei
    Zeng, Shan
    Chen, Jiaxu
    PHYTOMEDICINE, 2023, 109
  • [40] Bcl-XL and Mcl-1 upregulation by calreticulin promotes apoptosis resistance of fibroblast-like synoviocytes via activation of PI3K/Akt and STAT3 pathways in rheumatoid arthritis
    Jiao, Y.
    Ding, H.
    Huang, S.
    Liu, Y.
    Sun, X.
    Wei, W.
    Ma, J.
    Zheng, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : 841 - 849